These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

278 related items for PubMed ID: 12910508

  • 1. Hepatocellular carcinoma: is there a potential for chemoprevention using cyclooxygenase-2 inhibitors?
    Koga H.
    Cancer; 2003 Aug 15; 98(4):661-7. PubMed ID: 12910508
    [Abstract] [Full Text] [Related]

  • 2. Celecoxib: a potent cyclooxygenase-2 inhibitor in cancer prevention.
    Kismet K, Akay MT, Abbasoglu O, Ercan A.
    Cancer Detect Prev; 2004 Aug 15; 28(2):127-42. PubMed ID: 15068837
    [Abstract] [Full Text] [Related]

  • 3. Chemoprevention of breast cancer by targeting cyclooxygenase-2 and peroxisome proliferator-activated receptor-gamma (Review).
    Badawi AF, Badr MZ.
    Int J Oncol; 2002 Jun 15; 20(6):1109-22. PubMed ID: 12011987
    [Abstract] [Full Text] [Related]

  • 4. Cyclooxygenease-2 and hepatocellular carcinoma: is it a target for prevention?
    DuBois RN.
    Clin Cancer Res; 2001 May 15; 7(5):1110-1. PubMed ID: 11350871
    [No Abstract] [Full Text] [Related]

  • 5. Cyclooxygenase-2 as a potential target in the prevention and treatment of genitourinary tumors: a review.
    Pruthi RS, Derksen E, Gaston K.
    J Urol; 2003 Jun 15; 169(6):2352-9. PubMed ID: 12771797
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Cyclooxygenase 2: from inflammation to carcinogenesis.
    Ristimäki A.
    Novartis Found Symp; 2004 Jun 15; 256():215-21; discussion 221-6, 259-69. PubMed ID: 15027493
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. [Cyclooxygenase 2 and breast cancer. From biological concepts to therapeutic trials].
    Guastalla JP, Bachelot T, Ray-Coquard I.
    Bull Cancer; 2004 May 15; 91 Spec No():S99-108. PubMed ID: 15239337
    [Abstract] [Full Text] [Related]

  • 13. Rationale and feasibility of chemoprovention of hepatocellular carcinoma by cyclooxygenase-2 inhibitors.
    Hu KQ.
    J Lab Clin Med; 2002 Apr 15; 139(4):234-43. PubMed ID: 12024111
    [Abstract] [Full Text] [Related]

  • 14. Signal transduction pathways regulating cyclooxygenase-2 expression: potential molecular targets for chemoprevention.
    Chun KS, Surh YJ.
    Biochem Pharmacol; 2004 Sep 15; 68(6):1089-100. PubMed ID: 15313405
    [Abstract] [Full Text] [Related]

  • 15. Multifaceted roles of cyclooxygenase-2 in lung cancer.
    Riedl K, Krysan K, Põld M, Dalwadi H, Heuze-Vourc'h N, Dohadwala M, Liu M, Cui X, Figlin R, Mao JT, Strieter R, Sharma S, Dubinett SM.
    Drug Resist Updat; 2004 Jun 15; 7(3):169-84. PubMed ID: 15296859
    [Abstract] [Full Text] [Related]

  • 16. Characterization of cyclooxygenase-2 (COX-2) during tumorigenesis in human epithelial cancers: evidence for potential clinical utility of COX-2 inhibitors in epithelial cancers.
    Koki AT, Khan NK, Woerner BM, Seibert K, Harmon JL, Dannenberg AJ, Soslow RA, Masferrer JL.
    Prostaglandins Leukot Essent Fatty Acids; 2002 Jan 15; 66(1):13-8. PubMed ID: 12051953
    [Abstract] [Full Text] [Related]

  • 17. Cyclooxygenase-2-selective nonsteroidal anti-inflammatory drugs inhibit hepatocyte growth factor/scatter factor-induced angiogenesis.
    Sengupta S, Sellers LA, Cindrova T, Skepper J, Gherardi E, Sasisekharan R, Fan TP.
    Cancer Res; 2003 Dec 01; 63(23):8351-9. PubMed ID: 14678996
    [Abstract] [Full Text] [Related]

  • 18. Control of COX-2 gene expression through peroxisome proliferator-activated receptor gamma in human cervical cancer cells.
    Han S, Inoue H, Flowers LC, Sidell N.
    Clin Cancer Res; 2003 Oct 01; 9(12):4627-35. PubMed ID: 14555539
    [Abstract] [Full Text] [Related]

  • 19. Use of NSAIDs for the chemoprevention of colorectal cancer.
    Herendeen JM, Lindley C.
    Ann Pharmacother; 2003 Nov 01; 37(11):1664-74. PubMed ID: 14565811
    [Abstract] [Full Text] [Related]

  • 20. COX-2 inhibitors as radiosensitizing agents for cancer therapy.
    Davis TW, Hunter N, Trifan OC, Milas L, Masferrer JL.
    Am J Clin Oncol; 2003 Aug 01; 26(4):S58-61. PubMed ID: 12902857
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.